State Street Corporation 13D and 13G filings for G1 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-03 11:47 am Purchase |
2022-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
STATE STREET CORP STT |
179,736 0.360% |
37,530 (+26.39%) |
Filing |
| 2022-07-11 1:20 pm Sale |
2022-06-30 | 13G | G1 Therapeutics, Inc. GTHX |
STATE STREET CORP STT |
142,206 0.330% |
-4,159,407 (-96.69%) |
Filing |
| 2022-02-11 08:12 am Sale |
2021-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
STATE STREET CORP STT |
4,301,613 10.120% |
-81,999 (-1.87%) |
Filing |
| 2021-10-12 12:30 pm Purchase |
2021-09-30 | 13G | G1 Therapeutics, Inc. GTHX |
STATE STREET CORP STT |
4,383,612 10.350% |
1,803,793 (+69.92%) |
Filing |
| 2021-02-11 1:07 pm Purchase |
2020-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
STATE STREET CORP STT |
2,579,819 6.780% |
2,579,819 (New Position) |
Filing |